Reports, Whitepapers & Articles

As the biopharma industry intensifies its approach to patient engagement, these proven results are becoming critical success factors.

A new generation of patient engagement programs is creating an integrated environment where human engagement, technology and data co-exist in symbiosis.

Many companies are now shifting focus to how AI can be leveraged in the commercial stage, specifically in patient engagement given its profound potential to impact the last mile of care delivery.

Review key findings and takeaways from a national survey of HCPs to better understand the opportunities HCPs believe exist for enhancing the support provided by life science companies to both their medical practices and their patients.

As biopharma shifts its outlook to the post-COVID era, there is an opportunity for the industry to transform how it delivers patient and HCP engagement.

This issue explores how patients have responded to the digital transformation and why 86% of tech professionals said the pharma digital moment has arrived.

In our July Patient Services Report, we provide an in-depth look at the recent rare disease market and evaluate the investment biopharma is making to enhance patient and HCP support in this space.

Certain pandemic driven trends will continue to persist, thus having lasting impacts on how we develop commercial strategies.